| Literature DB >> 27824512 |
Hamed Manoochehri Khoshinani1, Saeid Afshar1, Rezvan Najafi1.
Abstract
Hypoxia is a common feature of malignant tumors. There is an interactive connection between hypoxia and chemoresistance, radioresistance, invasiveness, and angiogenesis. Therefore, tumor hypoxia has been considered as a validated target for treating cancer. This review focuses on the role of hypoxia on chemoresistance and radioresistance. In addition, we address several approaches targeting tumor hypoxia, known as hypoxia-targeted therapy.Entities:
Keywords: Chemoresistance; HIF-1; Hypoxia; Hypoxia-targeted therapy; Radioresistance
Mesh:
Substances:
Year: 2016 PMID: 27824512 DOI: 10.1080/07357907.2016.1245317
Source DB: PubMed Journal: Cancer Invest ISSN: 0735-7907 Impact factor: 2.176